These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 2593240)

  • 1. [Immunologic deficiency in HTLV-I infection].
    Taguchi H
    Rinsho Ketsueki; 1989 Oct; 30(10):1751-4. PubMed ID: 2593240
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunodeficiency and pulmonary diseases].
    Saito A
    Kokyu To Junkan; 1988 Dec; 36(12):1274-80. PubMed ID: 3074406
    [No Abstract]   [Full Text] [Related]  

  • 3. HTLV-1 and associated adult T-cell leukemia/lymphoma.
    Mahieux R; Gessain A
    Rev Clin Exp Hematol; 2003 Dec; 7(4):336-61. PubMed ID: 15129647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies of lymphocyte subpopulations of bronchoalveolar lavage fluid in HTLV-I seropositive patients with uveitis].
    Mukae H; Morikawa T; Kusano S; Sawa H; Sakito O; Morikawa N; Oda H; Kadota J; Kohno S; Hara K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Nov; 31(11):1397-404. PubMed ID: 8277609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An analysis of lymphocyte surface markers in HTLV-I-associated myelopathy (HAM)].
    Kuwasaki N; Yasuda K; Shoji H; Kaji M; Ayabe M
    Rinsho Shinkeigaku; 1988 Oct; 28(10):1192-6. PubMed ID: 3265368
    [No Abstract]   [Full Text] [Related]  

  • 6. Involvement of IL-2/IL-2R system activation by parasite antigen in polyclonal expansion of CD4(+)25(+) HTLV-1-infected T-cells in human carriers of both HTLV-1 and S. stercoralis.
    Satoh M; Toma H; Sugahara K; Etoh K; Shiroma Y; Kiyuna S; Takara M; Matsuoka M; Yamaguchi K; Nakada K; Fujita K; Kojima S; Hori E; Tanaka Y; Kamihira S; Sato Y; Watanabe T
    Oncogene; 2002 Apr; 21(16):2466-75. PubMed ID: 11971181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A patient with marked immunodeficiency in an HTLV-I carrier: a case report].
    Iroi A; Miyashita N; Nakamura S; Ohizumi H; Mizuno Y
    Rinsho Shinkeigaku; 2000 Feb; 40(2):135-9. PubMed ID: 10835933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti HTLV-I antibody titers in seropositive infected individuals].
    Galeno H; Ramírez E; Mora J; Ojeda M; Cartier L
    Rev Med Chil; 1994 Sep; 122(9):1004-7. PubMed ID: 7597329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Association between diffuse panbronchiolitis and HTLV-I infection].
    Mukae H; Higashiyama Y; Morikawa T; Kusano S; Morikawa N; Kadota J; Kohno S; Hara K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Jan; 32(1):17-24. PubMed ID: 8114368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiopathic CD4 lymphocytopenia and opportunistic infection--an update.
    Luo L; Li T
    FEMS Immunol Med Microbiol; 2008 Dec; 54(3):283-9. PubMed ID: 19049641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological features of HTLV-I myelopathy in Rio de Janeiro, Brazil, and in vitro effects of cyclosporin A.
    Andrada-Serpa MJ; Schor D; Araújo AQ; Rumjanek VM
    J Neurol Sci; 1996 Jul; 139(1):7-14. PubMed ID: 8836966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helminthic infection down-regulates type 1 immune responses in human T cell lymphotropic virus type 1 (HTLV-1) carriers and is more prevalent in HTLV-1 carriers than in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Porto AF; Santos SB; Muniz AL; Basilio V; Rodrigues W; Neva FA; Dutra WO; Gollob KJ; Jacobson S; Carvalho EM
    J Infect Dis; 2005 Feb; 191(4):612-8. PubMed ID: 15655786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HTLV-I and Behçet's disease.
    Igakura T; Kawahigashi Y; Kanazawa H; Nakagawa M; Osame M
    J Rheumatol; 1993 Dec; 20(12):2175-6. PubMed ID: 8014960
    [No Abstract]   [Full Text] [Related]  

  • 14. [Serological survey of human T lymphotropic virus type I (HTLV-1) IgG antibody in south region of Xinjiang].
    Sun H; Chen G; Du W; Ouyang X; Pang Y; He Y; Zhang J; Zhang Y; Zeng Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Dec; 11(4):366-8. PubMed ID: 15617250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impairment of host immune response against strongyloides stercoralis by human T cell lymphotropic virus type 1 infection.
    Hirata T; Uchima N; Kishimoto K; Zaha O; Kinjo N; Hokama A; Sakugawa H; Kinjo F; Fujita J
    Am J Trop Med Hyg; 2006 Feb; 74(2):246-9. PubMed ID: 16474078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple system atrophy with autonomic failure and human T-lymphotrophic virus type I infection.
    Yokota T; Miura Y; Yamada M; Kaneko K; Miyatake T
    Ann Neurol; 1994 Feb; 35(2):244. PubMed ID: 8141914
    [No Abstract]   [Full Text] [Related]  

  • 17. Sequential change of virus markers in seroconverters with community-acquired infection of human T lymphotropic virus type I.
    Okayama A; Stuver S; Iga M; Okamoto M; Mueller N; Matsuoka M; Yamaguchi K; Tachibana N; Tsubouchi H
    J Infect Dis; 2001 Apr; 183(7):1031-7. PubMed ID: 11237827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human T-lymphotropic type-1 virus specific antibody detected in sera of HIV/AIDS patients in Ghana.
    Adjei AA; Adiku TK; Kumi PF; Domfeh AB
    Jpn J Infect Dis; 2003 Apr; 56(2):57-9. PubMed ID: 12824686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-HTLV-1 tax antibody and tax-specific cytotoxic T lymphocyte are associated with a reduction in HTLV-1 proviral load in asymptomatic carriers.
    Akimoto M; Kozako T; Sawada T; Matsushita K; Ozaki A; Hamada H; Kawada H; Yoshimitsu M; Tokunaga M; Haraguchi K; Uozumi K; Arima N; Tei C
    J Med Virol; 2007 Jul; 79(7):977-86. PubMed ID: 17516523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Episcleritis associated with pigmentary retinal degeneration in an HTLV-I carrier.
    Nomura E; Kimura T; Yabuki K; Kurita M; Goto K; Ohno S
    Tokai J Exp Clin Med; 1998 Oct; 23(4):183-5. PubMed ID: 10359508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.